X-linked dominant chondrodysplasia punctata with decreased dihydroxyacetone phosphate acyltransferase activity

Dermatology. 1996;192(1):23-7. doi: 10.1159/000246308.

Abstract

Background: We examined an 18-month-old girl with typical clinical features of X-linked dominant chondrodysplasia punctata (CDPX2) with decreased activity of dihydroxyacetone phosphate acyltransferase (DHAP-AT), previously reported in CDPX2. On the other hand, steroid sulfatase, whose activity is deficient or decreased in X-linked ichthyosis and X-linked recessive chondrodysplasia punctata, has been reported to be normal in CDPX2, although all of these diseases have ichthyotic skin changes.

Objective: We measured the activity of DHAP-AT and steroid sulfatase of the patients fibroblasts to confirm the DHAP-AT abnormality in CDPX2.

Results: The DHAP-AT activity was remarkably reduced, but steroid sulfatase activity was within normal levels when compared with those of 2 healthy controls.

Conclusion: The abnormal metabolism in plasmalogen synthesis in CDPX2 was confirmed. It is, however, unknown how the decreased DHAP-AT activity is related to the skin changes.

Publication types

  • Case Reports
  • Clinical Trial

MeSH terms

  • Acyltransferases / analysis
  • Acyltransferases / metabolism*
  • Cells, Cultured
  • Chondrodysplasia Punctata / diagnosis
  • Chondrodysplasia Punctata / enzymology*
  • Chondrodysplasia Punctata / genetics*
  • Chondrodysplasia Punctata / physiopathology
  • Female
  • Fibroblasts / metabolism
  • Genetic Linkage
  • Humans
  • Infant, Newborn
  • X Chromosome / pathology*

Substances

  • Acyltransferases
  • glycerone-phosphate O-acyltransferase